Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  JAMA Surgery

• Publication date

  2015-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jamasurg.2015.0876PMID 26039049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of SEER Treatment Data With Medicare Claims

  2016cited by this paper
• Ductal carcinoma in situ of the breast: can biomarkers improve current management?

  2014cited by this paper
• Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

  2014cited by this paper
• Borderline Atypical Ductal Hyperplasia/Low-grade Ductal Carcinoma In Situ on Breast Needle Core Biopsy Should Be Managed Conservatively

  2013cited by this paper
• Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

  2013cited by this paper
• Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery.

  2013cited by this paper
• Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43

  2013cited by this paper
• Effect of three decades of screening mammography on breast-cancer incidence.

  2012cited by this paper
• Radical prostatectomy versus observation for localized prostate cancer.

  2012cited by this paper
• Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer.

  2012cited by this paper
• Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis

  2011cited by this paper
• An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

  2011cited by this paper
• Multiple Imputation by Chained Equations (MICE): Implementation in Stata

  2011cited by this paper
• Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

  2011cited by this paper
• Characterizing the impact of 25 years of DCIS treatment

  2011cited by this paper
• Overdiagnosis in cancer.

  2010cited by this paper
• Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.

  2010cited by this paper
• National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.

  2010cited by this paper
• Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.

  2010cited by this paper
• Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls

  2009cited by this paper
• Rethinking screening for breast cancer and prostate cancer.

  2009cited by this paper
• NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS).

  2009cited by this paper
• Much Ado About Nothing

  2007cited by this paper
• Statistical Analysis With Missing Data (2nd ed.) (Book)

  2004cited by this paper
• Use of SEER-Medicare Data for Measuring Cancer Surgery

  2002cited by this paper
• Histological and biological evolution of human premalignant breast disease.

  2001cited by this paper
• Multiple imputation of missing blood pressure covariates in survival analysis.

  1999cited by this paper
• Using Autopsy Series To Estimate the Disease Reservoir for Ductal Carcinoma in Situ of the Breast: How Much More Breast Cancer Can We Find?

  1997cited by this paper
• Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

  1995cited by this paper
• Statistical Analysis with Missing Data

  1988cited by this paper
• Model-Based Direct Adjustment

  1987cited by this paper
• Reducing Bias in Observational Studies Using Subclassification on the Propensity Score

  1984cited by this paper
• Intraductal carcinoma of the breast: Follow‐up after biopsy only

  1982cited by this paper

• Pure Ductal Carcinoma in Situ: Clinicopathological Experience from a Single Tertiary Care Center

  2026cites this paper
• Integrating radiomics into predictive models for low nuclear grade DCIS using machine learning

  2025cites this paper
• SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer

  2025cites this paper
• Should All Low-Grade Ductal Carcinoma In Situ Be Excised? Implications and Challenges of the COMET Trial

  2025cites this paper
• The effects of adjuvant endocrine therapy on long-term outcomes from ductal carcinoma in situ: a systematic review and meta-analysis

  2025cites this paper
• A Case Report of Short‐Term Metastasis After Surgery for Mammary Paget's Disease

  2025cites this paper
• Insights from a multi-institutional registry show duration of endocrine treatment for DCIS impacts second events

  2025cites this paper
• Identification of the optimal candidates to benefit from surgery and chemotherapy among elderly female breast cancer patients with bone metastases

  2025cites this paper
• Advancements in the Application of Convolutional Neural Networks in Ultrasound Imaging for Breast Cancer Diagnosis and Treatment

  2025cites this paper
• Ductal carcinoma in situ: Current diagnostic and therapeutic approaches

  2025cites this paper
• Spatiotemporal microenvironment landscape and malignant epithelial pattern transition in breast ductal carcinoma progression

  2025cites this paper
• Predictive Performance of Radiomic Features Extracted from Breast MR Imaging in Postoperative Upgrading of Ductal Carcinoma in Situ to Invasive Carcinoma

  2024cites this paper
• Update on the management of ductal carcinoma in situ of the breast: current approach and future perspectives

  2024influential citation
• An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ

  2024cites this paper
• Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.

  2024cites this paper
• Exploring non-surgical alternatives for low to intermediate-grade in situ ductal carcinoma of the breast using vacuum-assisted excision: the VACIS protocol

  2024cites this paper
• Survival outcomes after omission of surgery for ductal carcinoma in situ

  2024cites this paper
• Proportion of Patients With Ductal Carcinoma In Situ That Qualify for Observation Criteria Set Forth by Clinical Trials

  2024cites this paper
• Sonography-based multimodal information platform for identifying the surgical pathology of ductal carcinoma in situ

  2024cites this paper
• Duration of Endocrine Treatment for DCIS impacts second events: Insights from a large cohort of cases at two academic medical centers

  2024cites this paper
• Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes

  2024cites this paper
• Imaging Changes and Outcomes of Patients Undergoing Active Monitoring for Ductal Carcinoma In Situ: Seven-Year Follow-up Study.

  2024cites this paper
• Editorial Comment: Management of Low-Risk Ductal Carcinoma In Situ-What We Need to Know at a Time of Shifting Perceptions.

  2024cites this paper
• Tailored radiation dose according to margin width for patients with ductal carcinoma in situ after breast-conserving surgery

  2024cites this paper
• Outcomes from low-risk ductal carcinoma in situ: a systematic review and meta-analysis

  2024cites this paper
• Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort study.

  2024cites this paper
• Human Ductal Carcinoma In Situ: Advances and Future Perspectives.

  2023cites this paper
• Comparing core needle biopsy and surgical excision in breast cancer diagnosis: implications for clinical practice from a retrospective cohort study

  2023cites this paper
• Clinical Outcomes of Conservative Treatment for Low-Risk Ductal Carcinoma in Situ: A Systematic Review and Pooled Analysis.

  2023cites this paper
• Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer.

  2023cites this paper
• Histopathology of non-mass-like breast lesions on ultrasound

  2023cites this paper
• High-Grade Ductal Carcinoma In Situ of the Breast With Regressive Changes: Radiological and Clinicopathological Findings.

  2023cites this paper
• Evolving Treatment Paradigms for Low-Risk Ductal Carcinoma In Situ: Imaging Needs.

  2023cites this paper
• Nonclinical factors associated with the treatment of older women with newly diagnosed low‐grade ductal carcinoma in situ

  2023cites this paper
• Should low-risk DCIS lose the cancer label? An evidence review

  2023cites this paper
• Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance

  2023cites this paper
• Prediction of coexisting invasive carcinoma on ductal carcinoma in situ (DCIS) lesions by mass spectrometry imaging

  2023cites this paper
• A feature to promote better understanding of breast non-mass abnormalities

  2023cites this paper
• Ultrasound deep learning radiomics and clinical machine learning models to predict low nuclear grade, ER, PR, and HER2 receptor status in pure ductal carcinoma in situ

  2023cites this paper
• Survival Benefit of Adjuvant Chemotherapy in Node-Positive Breast Cancer With a 21-Gene Recurrence Score of 14 to 25: A Real-World Study Based on the Inverse Probability of Treatment Weighting Method.

  2023cites this paper
• The Biology and Management of Ductal Carcinoma in Situ of the Breast.

  2023cites this paper
• The value of DCE- MRI of the breast as a diagnostic tool in assessing amorphous calcifications in screening mammography

  2023cites this paper
• Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ.

  2023cites this paper
• Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ.

  2022cites this paper
• Quantitative classification of invasive and noninvasive breast cancer using dynamic magnetic resonance imaging of the mammary gland

  2022cites this paper
• Oncological safety of active surveillance for low-risk ductal carcinoma in situ - a systematic review and meta-analysis.

  2022cites this paper
• Hyaluronic acid nanoemulsions improve piplartine cytotoxicity in 2D and 3D breast cancer models and reduce tumor development after intraductal administration.

  2022cites this paper
• Development of an intraoperative breast cancer margin assessment method using quantitative fluorescence measurements

  2022cites this paper
• Cohort profile of the Sloane Project: methodology for a prospective UK cohort study of >15 000 women with screen-detected non-invasive breast neoplasia

  2022cites this paper
• Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy

  2022cites this paper
• A web-based personalized decision support tool for patients diagnosed with ductal carcinoma in situ: development, content evaluation, and usability testing

  2022cites this paper
• US, Mammography, and Histopathologic Evaluation to Identify Low Nuclear Grade Ductal Carcinoma in Situ.

  2022cites this paper
• Effect of postmastectomy radiotherapy on pT1-2N1 breast cancer patients with different molecular subtypes: A real-world study based on the inverse probability of treatment weighting method

  2022cites this paper
• Identifying ductal carcinoma in situ cases not requiring surgery to exclude postoperative upgrade to invasive ductal carcinoma

  2022cites this paper
• Overuse of Axillary Surgery in Patients with Ductal Carcinoma In Situ: Opportunity for De-escalation

  2022cites this paper
• Isolated ductal carcinoma in situ in patients presenting to two breast units in Johannesburg.

  2022cites this paper
• Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?

  2021cites this paper
• Use of the Twelve-Gene Recurrence Score for Ductal Carcinoma in Situ and Its Influence on Receipt of Adjuvant Radiation and Hormonal Therapy

  2021cites this paper
• Patient prognostic scores and association with survival improvement offered by postoperative radiotherapy for resected IIIA/N2 non‐small cell lung cancer: A population‐based study

  2021cites this paper
• ASO Author’s Reflections: Are Genomic Assays Informing the Management of Ductal Carcinoma in situ as They Have for Invasive Breast Cancer?

  2021cites this paper
• Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study

  2021cites this paper
• Dynamic changes in marital status and survival in women with breast cancer: a population-based study

  2021cites this paper
• Neoadjuvant endocrine therapy in women with operable breast cancer: A retrospective analysis of real-world use.

  2021cites this paper
• Which type of cancer is detected in breast screening programs? Review of the literature with focus on the most frequent histological features

  2021cites this paper
• De-escalating treatment for ductal carcinoma in situ - Has the pendulum swung too far? (Invited Opinion).

  2021cites this paper
• Role of breast MRI in predicting histologic upgrade risks in high-risk breast lesions: A review.

  2021cites this paper
• Microarray analysis of ductal carcinoma in situ samples obtained by puncture from surgical resection specimens

  2021cites this paper
• No Treatment Versus Partial Mastectomy Plus Radiation for Ductal Carcinoma In Situ

  2021cites this paper
• Biological features of ductal carcinoma in situ: clinical role and basis for treatment individualization

  2021cites this paper
• Abbreviated protocol combining quantitative diffusion-weighted imaging: a new strategy increasing diagnostic accuracy for breast magnetic resonance imaging?

  2021influential citation
• A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast

  2021cites this paper
• Neoadjuvant Endocrine Therapy for Operable Breast Cancer: A Retrospective Analysis of Real-World Use

  2021cites this paper
• Ductal Carcinoma in Situ: State-of-the-Art Review.

  2021cites this paper
• DCIS biology, language, and active surveillance: A survey of breast radiologists’ knowledge and opinions

  2021cites this paper
• Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast

  2021cites this paper
• A Review of the Recent Findings on Ductal Carcinoma In Situ of the Breast (DCIS)

  2020cites this paper
• Ductal Carcinoma In Situ Biology, Language, and Active Surveillance: A Survey of Breast Radiologists' Knowledge and Opinions.

  2020cites this paper
• Liquid biopsy for the detection of clinical biomarkers in early breast cancer: new insights and challenges.

  2020cites this paper
• Breast cancer in global health: beyond diversity and inequality

  2020cites this paper
• Interobserver Variability in Ductal Carcinoma In Situ of the Breast.

  2020cites this paper
• Genomic profiling reveals heterogeneous populations of ductal carcinoma in situ of the breast

  2020cites this paper
• Outcomes and Costs for Women After Breast Cancer: Preparing for Improved Survivorship of Medicare Beneficiaries.

  2020cites this paper
• Long-term Survival Outcomes of 'Low Risk' Ductal Carcinoma in situ from a Territory-wide Cancer Registry.

  2020cites this paper
• Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels

  2020cites this paper
• Estimating the natural progression of non-invasive ductal carcinoma in situ breast cancer lesions using screening data

  2020cites this paper
• A medicare-based comparative mortality analysis of active surveillance in older women with DCIS

  2020cites this paper
• Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US)

  2020cites this paper
• A medicare-based comparative mortality analysis of active surveillance in older women with DCIS

  2020cites this paper
• Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision

  2020cites this paper
• The challenge of avoiding over- and under-treatment in older women with ductal cancer in situ: A scoping review of existing knowledge gaps and a meta-analysis of real-world practice patterns.

  2020cites this paper
• Clinical feasibility of optical coherence elastography for tumour margin assessment in breast-conserving surgery

  2019cites this paper
• Estimating the magnitude of clinical benefit of local therapy in patients with DCIS.

  2019cites this paper
• Modeling ductal carcinoma in situ (DCIS) – an overview of CISNET model approaches

  2019cites this paper
• Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ

  2019cites this paper
• New Developments in Breast Cancer Screening and Treatment

  2019cites this paper
• Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study

  2019cites this paper
• Breast Density in a Contemporary Cohort of Women With Ductal Carcinoma In Situ (DCIS)

  2019cites this paper
• Optimization of composition and obtainment parameters of biocompatible nanoemulsions intended for intraductal administration of piplartine (piperlongumine) and mammary tissue targeting.

  2019cites this paper
• Surgery and adjuvant radiotherapy for unilateral ductal carcinoma in situ (DCIS) in women aged over 70 years: A population based cohort study.

  2019cites this paper
• Outcomes of Ductal Carcinoma In Situ According to Detection Modality: A Multicenter Study Comparing Recurrence Between Mammography and Breast US.

  2019cites this paper